INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2010

Glucosamine, chondroitin, or their combination did not produce clinically important reductions in joint pain or improvements in joint space width.

A network meta-analysis of 10 large-scale randomized controlled trials evaluated the effects of glucosamine, chondroitin, or their combination in 3,803 patients with hip or knee osteoarthritis. Compared with placebo on a 10 cm visual analogue scale, overall differences in pain intensity were -0.4 cm (95% credible interval -0.7 to -0.1 cm) for glucosamine, -0.3 cm (-0.7 to 0.0 cm) for chondroitin, and -0.5 cm (-0.9 to 0.0 cm) for the combination. None of the 95% credible intervals crossed the prespecified minimal clinically important difference of -0.9 cm. Differences in changes in minimal width of joint space were minute with credible intervals overlapping zero, and industry-independent trials showed smaller effects than commercially funded trials (P=0.02 for interaction).

Study type
Network meta-analysis of randomized controlled trials
Who was studied
3,803 patients across 10 trials with osteoarthritis of the knee or hip
What was measured
Pain intensity and change in minimal width of joint space

THE PAPER

Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis.

Wandel S, Jüni P, Tendal B, Nüesch E, Villiger PM, Welton NJ, Reichenbach S, Trelle S. BMJ, 2010.

PubMed 20847017 ↗DOI 10.1136/bmj.c4675 ↗

Bones & muscles

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.